Meet us at TCT 2026!

Welcome to HeartRecovery Skip to main content Search Icon used to search Close Icon used to close search modal Heart Recovery Contact Location & Language USA (English) USA (English) Change Back Select A Location North America USA English Europe, Middle East and Africa Europe English Deutschland Deutsch France Français Asia Pacific 日本 日本語 APAC English or Conditions Protected PCI Patient Identification Patient Selection Tool Clinical Evidence Patient Management Referring Provider Referral Criteria Tool AMI Cardiogenic Shock Patient Identification Clinical Evidence The Procedure Patient Management Right Heart Failure Patient Identification Clinical Evidence The Procedure Patient Management Surgical Applications Patient Identification Clinical Evidence Patient Management Acute Decompensated Heart Failure Products & Services Impella® Heart Pumps Impella CP® Impella 5.5® Impella RP Flex™ Companion Sheath SmartAssist® Technology Cost Effectiveness & Reimbursement ABIOMED® Collaborative Care Education Education Library On-Demand Courses Ongoing Studies Events Resources Downloads Calculators Research Grants Grants and Donations Job Board About Us Our Purpose Careers Search Icon used to search Close Icon used to close search modal Meet us at TCT 2026! October 31 – November 3, San Diego, CA Leading in Native Heart Recovery – Driving Innovation. Committed to Evidence. Advancing Patient Outcomes. See our events The U.S. Food and Drug Administration (FDA) has determined Impella is safe and effective for its intended uses. 1,500+ Peer reviewed clinical studies have published on Impella, including DanGer Shock RCT published in the New England Journal of Medicine 17 Clinical Guidelines and Consensus statements 450,000+ Patients have been treated with Impella heart pumps For Interventional Cardiologists Treat high-risk PCI, cardiogenic shock and right heart failure patients Learn More For Cardiac and Vascular Surgeons Escalate, stabilize and recover native organs with minimally-invasive surgical techniques Learn More For Nurses Use calculators, watch quick skills videos and learn patient management best practices Explore Resources For Fellows Advance your knowledge and develop skills to treat complex PCI patients Explore Resources For Referring Providers Are you caring for patients with heart disease? Learn more about how Impella heart pumps work, the benefits of Protected PCI with Impella and explore patient identification resources. Learn More Native Heart and Lung Recovery Conditions & Therapies Access education, clinical evidence and practice support for Protected PCI, AMI cardiogenic shock, right heart failure, surgical applications and severe lung failure. Learn More Products & Services Learn about the latest technology and how that technology may best support your patient. Learn More Education & Resources Abiomed provides a comprehensive training program for health care providers. Learn More Subscribe to receive the latest clinical data and priority access to resources. References *Compared to standard care with STEMI in cardiogenic shock. Møller J, et al. Long Term Outcomes of the DanGer Shock Trial N Engl J Med 2025. Møller, J., et al. (2024). Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock . N Engl J Med. Abiomed. (2024, September 13). Retrieved from PubMed search: “(Impella) AND ("Impella"[All Fields] AND 2000/01/01:2024/09/12[epdat]). Lawton, J. S. et al. (2021). 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation . https://doi.org/10.1161/CIR.0000000000001038 Chieffo, A. et al. (2021). 2021 Joint EAPCI/ACVC expert consensus document on percutaneous ventricular assist devices. EuroIntervention . https://eurointervention.pcronline.com/doi/10.4244/EIJY21M05_01 Riley, R. et al. (2020). 2020 SCAI position statement on optimal percutaneous coronary interventional